TREM2 and Alzheimer disease: Notwithstanding these constraints, our findings in brains of R47H TREM2 carriers, together with demonstrated effects of TREM2 KO and overexpression in myeloid cells, encourage further testing of the hypothesis that the variant exacerbates the neurodegenerative process in AD via chronic activation of the antiviral immune defense.